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abstract
 
Depletion of membrane cholesterol and substitution of endogenous cholesterol with its structural
analogues was used to analyze the mechanism by which cholesterol regulates volume-regulated anion current
(VRAC) in endothelial cells. Depletion of membrane cholesterol enhanced the development of VRAC activated in
a swelling-independent way by dialyzing the cells either with GTP
 
 
 
S or with low ionic strength solution. Using
M
 
 
 
CD–sterol complexes, 50–80% of endogenous cholesterol was substituted with a speciﬁc analogue, as veriﬁed
by gas-liquid chromatography. The effects of cholesterol depletion were reversed by the substitution of endoge-
nous cholesterol with its chiral analogue, epicholesterol, or with a plant sterol, 
 
 
 
-sitosterol, two analogues that
mimic the effect of cholesterol on the physical properties of the membrane bilayer. Alternatively, when cholesterol
was substituted with coprostanol that has only minimal effect on the membrane physical properties it resulted in
VRAC enhancement, similar to cholesterol depletion. In summary, our data show that these channels do not dis-
criminate between the two chiral analogues of cholesterol, as well as between the two cholesterols and 
 
 
 
-sitosterol,
but discriminate between cholesterol and coprostanol. These observations suggest that endothelial VRAC is regu-
lated by the physical properties of the membrane.
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INTRODUCTION
 
Changes in the level of cellular cholesterol are known
to affect numerous membrane proteins, including sev-
eral types of ion channels (e.g., Bolotina et al., 1989;
Barrantes, 1993; Chang et al., 1995; Lundbaek et al.,
1996; Romanenko et al., 2002b). Two general mecha-
nisms have been proposed for the regulation of mem-
brane proteins by cholesterol: (a) changing the physi-
cal properties of the membrane or (b) direct binding
between cholesterol and the proteins (for reviews see
Barrantes, 1993; Bastiaanse et al., 1997; Burger et al.,
2000). The basis for the ﬁrst mechanism is a well-
known observation that an increase in membrane cho-
lesterol restricts the motion of phospholipids, resulting
in lipid ordering (e.g., Demel et al., 1972; Stockton and
Smith, 1976), decrease in membrane ﬂuidity (e.g., Bru-
let and McConnell, 1976; Cooper, 1978; Xu and Lon-
don, 2000), and increase in membrane stiffness (Evans
and Needham, 1987; Needham and Nunn, 1990). The
latter was proposed to increase membrane deformation
energy altering the energetic cost of the transitions be-
tween the conformational states of the ion channels
(Lundbaek et al., 1996). This hypothesis is supported
by the studies showing that in model membranes, in-
crease in spontaneous monolayer curvature and thick-
ness of the membrane bilayer, factors that are among
the determinants of the membrane deformation en-
ergy (Huang, 1986; Nielsen et al., 1998), affect open
probability of antibiotic ion channels, gramicidin
(Lundbaek et al., 1997), and alamethicin (Keller et al.,
1993), and of bacterial mechanosensitive MscL chan-
nels (Perozo et al., 2002). There is little evidence, how-
ever, for the regulation of mammalian anion channels
by cholesterol-induced changes in the physical proper-
ties of the membrane bilayer in living cells.
We focus on endothelial volume–regulated Cl
 
 
 
 cur-
rent, a key process in cell volume homeostasis (for re-
view see Nilius et al., 1996) that is also implicated in the
regulation of cell cycle (Shen et al., 2000), cell prolifer-
ation (Manolopoulos et al., 1997; Voets et al., 1997),
and angiogenesis (Manolopoulos et al., 2000). In addi-
tion, more recent studies show that VRAC is sensitive to
mechanical ﬂuid shear stress (Barakat et al., 1999; Ro-
manenko et al., 2002a), suggesting that it may contrib-
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ute to shear stress-induced regulation of the endothe-
lium. Our earlier study has shown that VRAC is in-
versely dependent on the level of cellular cholesterol
(Levitan et al., 2000). The ﬁrst goal of this study is to
determine whether the effect of cholesterol on VRAC
may be accounted for by altering the mechanical con-
straint to cell swelling that is due to cytoskeleton. This
possibility has to be considered because cholesterol de-
pletion has been shown to release several cytoskeletal
proteins, such as actin, 
 
 
 
-actinin, and ezrin, from the
cellular membrane fractions (Harder et al., 1997), sug-
gesting that it may uncouple the membrane from the
underlying cytoskeleton and, consequently, decrease
cell stiffness and allow cells to swell more. In this study,
however, we show that cholesterol depletion enhances
VRAC in a swelling-independent way.
The second question addressed in this study is
whether the sensitivity of VRAC to cholesterol is due to
cholesterol-induced changes in the physical properties
of the membrane bilayer or due to speciﬁc sterol–pro-
tein interactions deﬁned as direct binding between
cholesterol and the channel protein or a modulatory
protein. Development of 
 
 
 
-cyclodextrin–cholesterol
donor/acceptor system that allows precise adjustment
of the level of cellular cholesterol to different levels
(Christian et al., 1997) and the substitution of choles-
terol with its structural analogues (Gimpl et al., 1997)
has provided strong tools to discriminate between the
speciﬁc and nonspeciﬁc effects of cholesterol. In our
recent study, we have shown that this method can be
used to substitute 
 
 
 
50% of endogenous cholesterol
with its chiral isomer epicholesterol in intact vascular
endothelial cells without apparent cell damage (Ro-
manenko et al., 2002b). Here, we extend this approach
to demonstrate a strong correlation between the effects
of cholesterol structural analogues on VRAC and their
known effects on the physical properties of the mem-
brane lipid bilayer providing the ﬁrst evidence that
VRAC is regulated by membrane physical properties.
 
MATERIALS AND METHODS
 
Modulation of Cellular Cholesterol Level and Substitution of 
Cholesterol with Sterol Analogues
 
Bovine aortic endothelial cells (BAECs) between passages 10
and 30 were grown in DMEM (Cell Grow) supplemented with
10% FBS (GIBCO BRL). BAECs were enriched with or depleted
of cholesterol by incubating them with methyl-
 
 
 
-cyclodextrin
(M
 
 
 
CD) saturated with cholesterol or with empty M
 
 
 
CD (not
complexed with cholesterol), as described previously (Levitan et
al., 2000). Brieﬂy, a small volume of cholesterol stock solution in
chloroform:methanol (1:1, vol:vol) was added to a glass tube and
the solvent was evaporated. Then, 2.5 or 5 mM M
 
 
 
CD solution in
DMEM medium without serum was added to the dried choles-
terol. The tube was vortexed, sonicated, and incubated overnight
in a shaking bath at 37
 
 
 
C. M
 
 
 
CD was saturated with cholesterol
at an M
 
 
 
CD:cholesterol molar ratio of 8:1, the saturation limit of
 
M
 
 
 
CD (Christian et al., 1997). In preparation for an experiment,
cells were washed three times with serum-free DMEM to remove
the serum from the growth medium. Cells were then incubated
with M
 
 
 
CD saturated solution or with M
 
 
 
CD solution containing
no cholesterol (empty M
 
 
 
CD) for 60 or 120 min. During the in-
cubation, cells were maintained in a humidiﬁed CO
 
2
 
 incubator
at 37
 
 
 
C. Control cells were treated similarly and incubated with
serum-free DMEM solution without any M
 
 
 
CD. After exposure
to M
 
 
 
CD, cells were washed three times with serum-free medium
and returned to the incubator. After treatment, cells were kept in
serum-free medium and were found to maintain the elevated or
the decreased level of cholesterol for at least 48 h, providing the
time window for the electrophysiological recordings (Table I).
Analogous procedure was used for substitution of membrane
cholesterol with epicholesterol, 
 
 
 
-sitosterol, and coprostanol us-
ing respective analogue instead of cholesterol for preparation of
M
 
 
 
CD–sterol complex. M
 
 
 
CD and sterols were purchased from
Sigma-Aldrich or Steraloids.
 
Measurement of Cellular Sterols
 
Quantitative analysis of membrane cholesterol and epicholes-
terol was done as described previously (Romanenko et al.,
2002b). Brieﬂy, total lipid was extracted from the cell monolayers
using isopropanol with addition of known amount of cholesteryl
methyl ether (CME) as an internal standard. The extracts were
dried in the ﬂow of N
 
2
 
 at 35
 
 
 
C, reextracted with chlorophorm:
methanol:water system (Bligh and Dyer, 1959), dissolved in CS
 
2
 
,
and analyzed by gas-liquid chromatography (GLC) as described
previously (Ishikawa et al., 1974; Klansek et al., 1995). Cell pro-
tein was determined on the lipid-extracted monolayer using a
modiﬁcation (Markwell et al., 1978) of the method of Lowry
(Lowry et al., 1951). All mass values were normalized on the basis
of cell protein. Quantiﬁcations of membrane 
 
 
 
-sitosterol and co-
prostanol were performed using the same procedure.
 
Electrophysiological Recording
 
Ionic currents were measured using the whole-cell and outside-out
excised patch conﬁgurations (Hamill et al., 1981). Pipettes were
pulled (SG10 glass; Richland Glass) to give a ﬁnal resistance of 2–6
M
 
 
 
. A saturated salt agar bridge was used as the reference elec-
trode. Currents were recorded using an EPC9 ampliﬁer (HEKA
Electronik) and accompanying acquisition and analysis software
(Pulse & PulseFit; HEKA Electronik). Whole-cell capacitance and
series resistance were compensated and monitored throughout
the recording. Whole-cell currents were elicited by 500-ms linear
voltage ramps from 
 
 
 
60 to 
 
 
 
60 mV with an interpulse interval of
5 s The holding potential between the ramps was 
 
 
 
60 mV. Excised
patches were pulled from the cells after full VRAC development
and single channel current was recorded using a voltage-step pro-
 
TABLE I
 
Levels of Sterols in BAECs Treated with M
 
 
 
CD and
M
 
 
 
CD-cholesterol Complexes
 
Conditions Cholesterol, 
 
 
 
g/mg protein
5 mM M
 
 
 
CD, 2 h 7.45 
 
  
 
0.45
2.5 mM M
 
 
 
CD, 1 h 14.91 
 
  
 
0.96
Control 22.62 
 
  
 
2.02
2.5 mM M
 
 
 
CD-cholesterol, 1 h 31.92 
 
  
 
2.16
5 mM M
 
 
 
CD-cholesterol, 2 h 46.44 
 
  
 
1.46
Cholesterol levels in BAECs exposed to M
 
 
 
CD and M
 
 
 
CD-cholesterol
complexes for indicated periods and in control cells measured by GLC
(
 
n
 
 
 
  
 
8–12). 
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tocol, as described previously by (Jackson and Strange, 1995). Sin-
gle-channel recordings were done with a 50-
 
 
 
s sampling interval
and ﬁltered at 500 Hz. The external recording solution contained
(in mM): 150 NaCl, 1 EGTA, 2 CaCl
 
2
 
, 10 HEPES, pH 7.3. The ba-
sic internal solution contained (in mM): 120 or 140 Cs-Glutamate,
10 HEPES, 4 ATP, pH 7.3 (CsOH), with free [Ca
 
2
 
 
 
] 
 
 
 
10 nM (0.1
CaCl
 
2
 
, 1.1 EGTA). VRAC was activated by either supplementing
the internal solution with 100 
 
 
 
M GTP
 
 
 
S or by lowering the con-
centration of Cs-Glutamate to 90 mM. The osmolarities of all solu-
tions were determined immediately before recording with a vapor
pressure osmometer (Wescor, Inc.) and were adjusted by the addi-
tion of sucrose, as required. All chemicals for the recording solu-
tions were obtained from Fisher Scientiﬁc or Sigma-Aldrich. Only
cells that retained normal morphology after the M
 
 
 
CD treatments
were taken for the analysis.
 
Analysis 
 
Ionic strength
 
 
 
(
 
 
 
i
 
) was calculated as: 
 
 
 
i
 
 
 
 
 
 1/2 
 
 
 
m
 
i
 
z
 
i
2
 
, half the
sum of the molalities of each ion in the solution (m
 
i
 
) multiplied
by the square of its charge (z
 
i
 
) (Moore, 1972). It was approxi-
mated that zwitterions of HEPES and glutamate contribute to
ionic strength of the solutions as monoanionic acids with pKa 7.6
and 4.3, respectively. 120 Cs-Glutamate, 10 HEPES, 0.1 CaCl
 
2
 
, 1.1
EGTA, 4 ATP, pH 7.3 (CsOH) has ionic strength 0.133 (
 
 
 
 was
1.039 
 
 
 
 0.002 kg/l). Analogous solutions with 90 or 140 mM Cs-
Glutamate have ionic strengths of 0.104 and 0.153, respectively
(
 
 
 
 were 1.041 
 
 
 
 0.004 kg/l and 1.036 
 
 
 
 0.002 kg/l, respectively).
The calculations were performed using WINMAX v2.40 software
(Bers et al., 1994).
Activation rates of VRAC were calculated as maximal slopes of
the linear regression of the time-courses of the current increase
normalized by the peak amplitude of the current and maximal
current densities were calculated by normalizing peak VRAC cur-
rents by the cell capacitance. Analysis of the single-channel prop-
erties was performed using TAC software (Bruxton). Statistical
analysis of the data was performed using a standard two-sample
Student’s 
 
t
 
 test and was considered signiﬁcant if two-tailed P val-
ues were 
 
 
 
0.05. All values are presented as means 
 
  
 
SE.
 
RESULTS
 
Cholesterol Depletion Enhances VRAC in the Absence of 
Osmotic Stress
 
Two strategies were employed in this study to activate
VRAC in the absence of osmotic stress: (a) dialyzing the
cells with guanosine 5
 
 
 
-
 
O
 
-(3-thiotriphosphate) (GTP
 
 
 
S)
(Doroshenko et al., 1991; Nilius et al., 1999; Estevez et
al., 2001), and (b) a decrease in the intracellular ionic
strength (
 
 
 
i
 
) (Nilius et al., 1998; Voets et al., 1999; Sa-
birov et al., 2000). To test the sensitivity of GTP
 
 
 
S-
induced and 
 
 
 
I
 
-induced VRAC to the level of cellular
cholesterol, the cells were exposed to “empty” M
 
 
 
CD for
2 h resulting in removal of 
 
 
 
70% of cellular cholesterol
(Fig. 1 A). Intracellular dialysis of the cells with GTP
 
 
 
S
(100 
 
 
 
M) induced transient development of VRAC
(Fig. 1 B), consistent with the earlier studies (Doro-
shenko et al., 1991; Nilius et al., 1999; Estevez et al.,
2001). Depletion of cellular cholesterol resulted in a
signiﬁcant increase in current density (Fig. 1, B and C),
indicating that the effect of cholesterol can occur in the
absence of cell swelling and it cannot be accounted for
by an increase in cell swelling. The rate of current acti-
vation was not affected by cholesterol depletion.
To test whether the observed effect may be due to the
effect of cholesterol depletion on the unitary conduc-
tance of VRAC channels, single-channel events were re-
corded in excised outside-out conﬁgurations after the
current has developed (Fig. 1 D). After the excision,
single-channel events can be observed under strong
depolarization that induces channel closing. In most
cases, when the channels close they stay closed for a
prolonged period of time (Fig. 1 D, a), but in some
cases the channels may ﬂicker between the open and
closed states for a short period of time before they close
completely (Fig. 1 D, b). The amplitudes of the single-
channels events were indistinguishable in cells de-
pleted of cholesterol and in control cells (Fig. 1 E).
In our previous study we have shown that swelling-
activated VRAC becomes insensitive to changes in the
membrane cholesterol level when activated by strong
osmotic gradient, indicating the maximal number of
swelling-activated channels is not altered by changes in
the membrane cholesterol (Levitan et al., 2000). Here
we also tested whether the effect of cholesterol deple-
tion on GTP
 
 
 
S-induced VRAC is different at low and at
saturating levels of GTP
 
 
 
S. VRAC currents were re-
corded in BAECs dialyzed with increasing concentra-
tion of GTP
 
 
 
S (Fig. 2 A). The ﬁgure shows that at 50–
100 
 
 
 
M GTP
 
 
 
S VRAC reached an apparent maximum.
To conﬁrm that at 100 
 
 
 
M GTP
 
 
 
S the current indeed
reaches the maximal value, average maximal current
densities were compared at 100 
 
 
 
M and 2 mM GTP
 
 
 
S
concentrations when recorded the same day and were
found virtually indistinguishable (P 
 
  
 
0.96, 
 
n
 
 
 
  
 
13–
15). Fig. 2 B shows that the effect of cholesterol deple-
tion on VRAC activated at low GTP
 
 
 
S concentration is
similar to that at saturating GTP
 
 
 
S concentration.
Similarly to GTP
 
 
 
S-activated VRAC, cholesterol
depletion signiﬁcantly enhanced VRAC development
when the current was activated by decreasing the intra-
cellular ionic strength (Fig. 3 A and B). The intracellu-
lar ionic strength was reduced by dialyzing the cells
with low salt solution ( i   104 mM) where the solution
was adjusted with sucrose to maintain normal osmolar-
ity (310 mOsM). Furthermore, cholesterol depletion
alone was sufﬁcient to induce spontaneous VRAC activ-
ity (Fig. 3, C and D). When dialyzed with isosmotic in-
tracellular solution with  i   153 mM, control cells de-
velop only a low-amplitude, nonselective cation current
and virtually no VRAC (Levitan and Garber, 1998). In
contrast, cells depleted of cholesterol show clear VRAC
development (Fig. 3 C) with the maximal current den-
sity in cholesterol depleted cells being  4 times higher
than the baseline current density (Fig. 3 D).
To analyze further the quantitative relationship be-
tween GTP S-induced and low  i -induced VRAC and80 Regulation of VRAC by Cholesterol Analogues
cellular cholesterol, the level of cellular cholesterol was
titrated by exposing the cells to either 2.5 or 5 mM
M CD or M CD–cholesterol complex. The level of
free cholesterol was measured for every experimental
condition and, as expected, the efﬁciency of choles-
terol depletion/enrichment was proportional to M CD
concentration. Fig. 4 shows maximal current densities
of GTP S-induced and low  i-induced VRAC plotted as
a function of free cellular cholesterol. The functional
dependence of both GTP S-induced and low  i-
induced VRAC current densities on cellular-free cho-
lesterol was ﬁtted with a single exponential (correlation
coefﬁcients of 0.99 for both GTP S-induced and for
low  i-induced VRAC). While it is remarkable that the
quantitative dependences of GTP S-induced and  i-
induced VRAC on the level of cellular cholesterol are
virtually identical, they differ from the cholesterol de-
pendence of swelling-induced VRAC. The main differ-
ence is that swelling-induced VRAC was sensitive to high
levels of cholesterol (Levitan et al., 2000). These obser-
vations suggest that cholesterol may affect VRAC devel-
opment by more than one mechanism and while
GTP S- and  i-induced VRAC retains its sensitivity to
the low levels of cholesterol, it loses the component
that is sensitive to the high level of cellular cholesterol.
VRAC Development Is Not Sensitive to the Substitution of 
Cholesterol by Epicholesterol
As described in our previous study (Romanenko et al.,
2002b), exposing the cells to 2.5 mM M CD saturated
with epicholesterol resulted in removal of  50% of en-
dogenous cholesterol, which was substituted with the
similar amount of epicholesterol during the same expo-
sure (Fig. 5 A). The effect of cholesterol/epicholesterol
substitution on VRAC development was tested for both
GTP S-induced and low  i-induced currents (Fig. 5, B
and D, respectively). Our observations show that substi-
tution of 50% of endogenous cholesterol with epicho-
lesterol had no signiﬁcant effect on either GTP S-
induced or low  i-induced VRAC, indicating that the
channels are insensitive to the chirality of the choles-
terol isomer in the membrane (Fig. 5, C and D). In-
Figure 1. Effect of cholesterol depletion on
whole-cell and single-channel VRAC induced by
GTP S. (A) Cholesterol levels in BAECs exposed
to 5 mM M CD and in control cells measured by
GLC (n   8–12; *P   0.01). (B) Typical families
of current traces recorded from individual cells
dialyzed with 100  M GTP S elicited by applica-
tion of linear voltage ramps materials and
methods. The time-courses of VRAC current
densities that developed in the same cells calcu-
lated by normalizing the maximal current ampli-
tudes ( 60 mV) of each individual ramp by the
cell capacitance. (C) The activation rates and
mean peak current densities of VRAC in cells
treated with M CD or control cells (n   11–19).
(D) Single-channel currents recorded in the out-
side-out excised patch conﬁguration after a depo-
larization step from  60 to  140 mV. Examples
of recordings when the channels were closing for
a prolonged period of time (a) and the channels
that ﬂickered between the open and closed states
(b). (E) Unitary conductances of the channels re-
corded in the membranes of the cells depleted of
cholesterol and control cells.81 Romanenko et al. 
deed, when VRAC activity in M CD-epicholesterol–
treated cells was plotted as a function of total cellular
sterol level it fell exactly on the same exponential curve
that was obtained by titrating the levels of cellular cho-
lesterol (Fig. 9). The equivalent result was observed
when cells, depleted of cholesterol by exposing them to
empty M CD, were reloaded with epicholesterol by ex-
posing them to M CD complexed with epicholesterol.
After the reloading, VRAC current density returned to
the control level. Since the sensitivities of GTP S- and
 i-induced VRAC to both cholesterol depletion and to
the substitution of cholesterol with epicholesterol ap-
pear to be very similar, the rest of the substitution exper-
iments were performed only for GTP S-induced VRAC.
Substitution of Endogenous Cholesterol with  -sitosterol has a 
Small Effect on VRAC Activity
To verify further that VRAC activity is regulated by the
physical properties of the membrane bilayer but not by
speciﬁc cholesterol–protein interactions, we have substi-
tuted endogenous cholesterol with a plant sterol,  -sito-
sterol that, similarly to the two chiral forms of choles-
terol, decreases membrane ﬂuidity (Gimpl et al., 1997)
and induces formation of the structural lipid domains
(Xu and London, 2000). As with cholesterol/epicholes-
terol substitution, we have optimized the conditions of
the exposure so that  50% of endogenous cholesterol
was substituted with the appropriate amount of  -sitos-
Figure 2. Effect of choles-
terol depletion is conserved
when VRAC is induced by
various concentrations of
GTP S. (A) Peak current
densities of VRAC were mea-
sured in control cells (n  
5–13). (B) The mean peak
current densities of VRAC in
cells treated with M CD or
control cells (n   5–13).
Figure 3.  Cholesterol depletion
up-regulates low  i-induced VRAC
and induces VRAC activation at high
 i. (A and C) Typical families of cur-
rent traces and time courses re-
corded in cholesterol-depleted and
control cells dialyzed with solution
with either  i   104 mM (A)  i  
153 mM (C). (B and D) The activa-
tion rates and the mean peak cur-
rent densities in cells dialyzed with
either low or high  i solutions, re-
spectively (n   3–10).82 Regulation of VRAC by Cholesterol Analogues
terol. We have found, however, that cholesterol/ -sitos-
terol substitution invariably resulted in some decrease in
the total sterol level. Typically the level of total sterol was
decreased by  20% (Fig. 6 A). The reason for this partial
depletion effect is probably based on the relative afﬁni-
ties of M CD and of the membrane to the particular ste-
rol. The level of VRAC current density in  -sitosterol–
treated cells was slightly but not signiﬁcantly higher than
in control cells (Fig. 6, B and C). This increase, however,
is accounted for by the decrease in the total sterol level in
these cells, which is apparent from plotting VRAC cur-
rent density as a function of the total sterol level for dif-
ferent experimental conditions (Fig. 9).
Effect of Cholesterol/coprostanol Substitution Is Similar to that 
of Cholesterol Depletion
Finally, we have substituted endogenous cholesterol
with coprostanol that, in contrast to cholesterol, has
only minimal effect on ﬂuidity of the membrane (Gimpl
et al., 1997; Xu and London, 2000). Coprostanol parti-
tioned easily into the membrane resulting in 70% cho-
lesterol/coprostanol substitution with no change in to-
tal sterol level (Fig. 7 A). Under these experimental
conditions, VRAC activity was strongly facilitated (Fig.
7, B and C) and was almost identical to the current in
cholesterol-depleted cells (Fig. 9).
Substitution of Endogenous Cholesterol with its Analogues has 
No Effect on VRAC Unitary Conductance
Similarly to cholesterol depletion, we tested whether
partial substitution of cellular cholesterol with epi-
cholesterol,  -sitosterol, or coprostanol affects the uni-
tary conductance of VRAC channels (Fig. 8). We have
found that the amplitudes of the single-channel events
were indistinguishable in cells at all four conditions.
Dependence of VRAC on Total Sterol Level Versus
Cholesterol Alone
Fig. 9 summarizes the ﬁndings of this study by showing
maximal VRAC amplitudes in different substitution ex-
periments as a function of total cellular sterol (Fig. 9 A)
or as a function of cholesterol alone (Fig. 9 B). The ﬁg-
ure shows that when cholesterol is substituted with epi-
cholesterol or with  -sitosterol, VRAC current density is
identical to the value predicted from the VRAC/total
sterol curve but when cholesterol is substituted with co-
prostanol the level of VRAC current density is signiﬁ-
cantly higher than that predicted by the VRAC/total
sterol curve. In contrast, if VRAC is plotted as a func-
tion of cholesterol alone, the picture reverses. When
cholesterol is substituted with coprostanol, VRAC cur-
rent density is identical to the value predicted by the
VRAC/cholesterol curve, whereas when cholesterol is
substituted with epicholesterol or  -sitosterol, it falls
signiﬁcantly lower than the predicted value. These ob-
servations lead to the conclusion that VRAC is regu-
lated by the physical properties of the membrane bi-
layer and not by speciﬁc sterol–protein interactions.
DISCUSSION
The role of cholesterol in regulation of VRAC develop-
ment was studied by analyzing the sensitivity of VRAC
to changes in the cellular level of cholesterol and to
substitution of endogenous cholesterol with its struc-
tural analogues. The main ﬁndings of this study are: (a)
cholesterol depletion enhances VRAC activity in a
swelling-independent way, (b) VRAC unitary conduc-
tance is not affected by changes in the membrane ste-
rol composition, and (c) VRAC is insensitive to the sub-
stitution of cholesterol with the sterols whose effects on
membrane ﬂuidity were shown to be similar to that of
cholesterol, but is strongly affected by the substitution
of cholesterol with a sterol whose effect on membrane
ﬂuidity is similar to that of cholesterol depletion.
The fundamental question for understanding the
mechanisms by which cholesterol affects the function of
membrane proteins is whether cholesterol regulates pro-
tein function by speciﬁc sterol–protein interactions (di-
rect binding to the protein of interest or to a modulatory
protein) or by changing the physical properties of the
lipid environment. Three experimental approaches are
Figure 4. Functional dependence of GTP S-induced (A) and low
 i-induced (B) VRAC on the level of cellular cholesterol. Peak cur-
rent densities were measured in cells treated with 5 mM or 2.5 mM
M CD or M CD saturated with cholesterol. The curves were ﬁt to a
single exponent with correlation coefﬁcients of 0.99 (n   8–15).83 Romanenko et al. 
commonly used to test the effect of cholesterol on mem-
brane proteins in living cells. The ﬁrst approach is de-
pleting the cells of or enriching them with cholesterol by
exposing the cells to cyclodextrins, water-soluble cyclic
carbohydrates with high speciﬁcity for cholesterol (e.g.,
Klein et al., 1995; Christian et al., 1997; Gimpl et al.,
1997). As expected, cholesterol removal increases mem-
brane ﬂuidity (Gimpl et al., 1997) and decreases lipid or-
dering (Gidwani et al., 2001) but altering the level of
cholesterol alone cannot discriminate between the two
mechanisms because both the amount of cholesterol
and the physical properties of the membrane are altered
at the same time. Another approach is to sequester cho-
lesterol with a polyene antibiotic ﬁlipin (e.g., (Gimpl et
al., 1997; Scanlon et al., 2001; Mitter et al., 2003)). This
treatment, however, decreases the local concentration of
cholesterol and, therefore, bears the same limitations
as cholesterol depletion. Finally, membrane cholesterol
can be modiﬁed by its enzymatic degradation with cho-
lesterol oxidase (e.g., Gimpl et al., 1997; Pang et al.,
1999; Scanlon et al., 2001). This method has the advan-
tage of preserving membrane ﬂuidity (Gimpl et al.,
1997); however, it tests only the impact of one speciﬁc
modiﬁcation of cholesterol structure. In this study, we
use an alternative approach of quantitative substitution
of endogenous cholesterol by its structural analogues.
This approach is based on application of cyclodextrin
that was ﬁrst used to titrate cellular cholesterol to differ-
ent levels (Klein et al., 1995; Christian et al., 1997) and
then developed further to introduce various sterols into
membrane vesicles (Gimpl et al., 1997).
In this study, we substitute endogenous cellular cho-
lesterol with three of its structural analogues: the cho-
lesterol synthetic chiral analogue epicholesterol, the
plant sterol  -sitosterol, and coprostanol. Comparing
effects of cholesterol and epicholesterol is the most
commonly used method to discriminate between spe-
ciﬁc and nonspeciﬁc effects of cholesterol on protein
function (Mickus et al., 1992; Gimpl et al., 1997; Sook-
saware and Simmonds, 2001). Indeed, cholesterol and
epicholesterol are known to reside at signiﬁcantly dif-
ferent angles in the membrane (Murari et al., 1986)
Figure 5. Substitution of cholesterol with epic-
holesterol has no effect on GTP S- and low  i-
induced VRAC. (A) Structure of epicholesterol
(note   conformation of 3-OH group), GLC pro-
ﬁle of the lipid extract of epicholesterol-treated
cells [the peaks are of internal standard (CME)
(a), epicholesterol (b) and cholesterol (c)], and
the concentrations of cholesterol (lighter portion
of the bar) and epicholesterol (darker portion)
measured in cells treated with 2.5 mM M CD sat-
urated with epicholesterol and in control cells
(n   8–9). (B and D) Typical families of current
traces and VRAC time courses in cells treated with
2.5 mM M CD saturated with epicholesterol and
in a control cell recorded upon activation of
VRAC with GTP S (B) and low  i (C). (C and E)
The activation rates and the peak current densi-
ties in cells exposed to M CD-epicholesterol and
in control cells for both in GTP S- and  i-induced
VRAC (n   6–52).84 Regulation of VRAC by Cholesterol Analogues
Figure 6. Substitution of cholesterol with  -sitosterol has no sig-
niﬁcant effect on GTP S-induced VRAC. (A) Structure of  -sitos-
terol (note the additional ethyl group at position 24), GLC proﬁle
of the lipid extract of  -sitosterol-treated cells [(a) CME, (b) cho-
lesterol, and (c)  -sitosterol], and the concentrations of choles-
terol (lighter portion of the bar) and of  -sitosterol (darker por-
tion) measured in cells treated with 5 mM M CD saturated with
 -sitosterol and in control cells (n   6). (B) Typical families of cur-
rent traces and the time-courses of GTP S-induced VRAC re-
corded in a  -sitosterol–treated cell and in control cell. (C) The
peak current densities in treated cells were not signiﬁcantly differ-
ent than in control cells (n   13–21).
Figure 7. Substitution of cholesterol with coprostanol signiﬁ-
cantly enhances GTP S-induced VRAC. (A) Structure of copros-
tanol (note the reduced  5 double bond), GLC proﬁle of the lipid
extract of 1 mM M CD-coprostanol treated cells [(a) CME, (b) co-
prostanol, and (c) cholesterol], and the concentrations of the ste-
rols cholesterol (lighter portion of the bar) and coprostanol
(darker portion) (n   3). (B) Typical families of current traces
and VRAC time-courses of GTP S-induced VRAC in a coprostanol-
treated cell and in a control cell. (C) The peak current densities
(n   21–23; *P   0.01).85 Romanenko et al. 
and therefore are expected to differ in direct binding
to membrane proteins.  In addition, cholesterol was
substituted with  -sitosterol, which incorporates a struc-
tural modiﬁcation at the opposite end of the choles-
terol molecule than epicholesterol but, similarly to epi-
cholesterol, is known to have an effect on membrane
ﬂuidity indistinguishable from that of cholesterol. Co-
prostanol, on the other hand, was chosen because its ef-
fect is similar to that of cholesterol depletion. Effects of
these sterols on the physical properties of the mem-
brane were measured both in simple reconstituted
lipid systems (Xu and London, 2000) and in mem-
brane vesicles isolated from epithelial cells HEK293
(Gimpl et al., 1997; Xu and London, 2000). The effects
of the sterols on membrane ﬂuidity in membrane vesi-
cles are very similar to their effects in reconstituted
lipid systems suggesting that these observations reﬂect
general effects of the sterols on membrane properties.
Our study shows that the effects of the three analogues
on VRAC correlate closely to their effects on the physi-
cal properties of the membrane. Therefore, while it is
not feasible to completely exclude the possibility that
Figure 8. Substitution of cholesterol with its analogues does not
affect unitary conductance of GTP S-induced VRAC. (A) Exam-
ples of single-channel currents recorded in the outside-out excised
patch conﬁguration after a depolarization step from  60 to  140
mV. (B) Unitary conductances of the channels recorded in the
membranes of the cells substituted with cholesterol analogues and
control cells (n   3–5).
Figure 9. Functional dependence of GTP S-induced VRAC on
the level of total sterol (A) and on the level of endogenous choles-
terol (B) in sterol substitution experiments. (A) The mean peak
current densities plotted as a function of total sterol level in cells
treated with M CD or M CD saturated with cholesterol ( ), in
the cells treated with M CD saturated with epicholesterol ( ),
in the cells treated with M CD saturated with sitosterol ( ), and
in the cells treated with M CD saturated with coprostanol ( ). All
the values were normalized by their respective values in control
cells. (B) The graph represents the same set of data as in A, plot-
ted as a function of cellular cholesterol alone.86 Regulation of VRAC by Cholesterol Analogues
the sterols regulate VRAC by directly binding to the
channel because the molecular nature of VRAC is not
yet identiﬁed,  our current observations suggest that
physical properties of the membrane play an important
role in the regulation of VRAC activity.
What are the molecular mechanisms that may be re-
sponsible for the regulation of membrane proteins by
the physical properties of the membrane? First, since the
unitary conductance of VRAC is not affected, we can ex-
clude the possibility that sterols affect VRAC pore prop-
erties. We also show that the effect of cholesterol deple-
tion is not abolished at the saturating levels of GTP S,
indicating that cholesterol does not affect the GTP S-
dependent transition between the closed and the open
states. If the effect is abolished, as we have demonstrated
earlier for swelling-activated VRAC (Levitan et al., 2000),
then it strongly suggests that it is not due to an increase
in the number of the channels. If, however, the effect is
not abolished at the saturating level of the stimulus, as is
the case for GTP S-sensitive VRAC, it suggests that cho-
lesterol affects the transition that is not dependent on
GTP S and the simplest explanation is that cholesterol
alters the distribution between the population of closed
unavailable channels and the joint population of closed
but available and open channels.
On a mechanistic level, one possibility is that choles-
terol affects the distribution between different confor-
mational states of the channels, as was proposed by the
membrane deformation model. Speciﬁcally, the model
suggests that changes in the lipid composition of the
membrane that affect the structural stress of the mem-
brane are expected to alter the energetic cost of the
transition between the open and the closed states of
the channels (Lundbaek and Andersen, 1994; Lund-
baek et al., 1996). Indeed, sterols that increase the or-
dering of phospholipids (cholesterol, epicholesterol,
and  -sitosterol) also inhibit the current, whereas cho-
lesterol depletion that has a disordering effect on the
membrane (Gidwani et al., 2001) as well as substitution
of membrane cholesterol with an analogue, which does
not increase ordering (Xu and London, 2000), facili-
tate channel activity. The correlation of the sterol ef-
fects on the transition between the nonavailable and
the available channels with the change in bilayer physi-
cal properties suggests that this regulation involves a
change in the cost of bilayer deformation. Another pos-
sible mechanism that may be responsible for the sensi-
tivity of volume-regulated anion channels to choles-
terol is segregation of the proteins into cholesterol-rich
domains (lipid rafts). Organization of the lipid rafts
is driven by lipid–lipid, protein–lipid, and protein–
protein interactions (Lai, 2003), and these domains
may serve as scaffolds for protein–protein interac-
tions (Brown and London, 1998; Simons and Toomre,
2000). The two mechanisms are distinct but not mutu-
ally exclusive because segregation into a raft may affect
channel function by altering its lipid environment.
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